ArticleCancer immunology, immunotherapy : CII2011

CTL recognition of a novel HLA-A*0201-binding peptide derived from glioblastoma multiforme tumor cells.

Cheryl E Myers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.